Profund Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $685K | Sell |
13,076
-377
| -3% | -$19.9K | 0.02% | 448 |
|
|
2026
Q1 | $742K | Sell |
13,453
-2,093
| -13% | -$113K | 0.03% | 430 |
|
|
2025
Q4 | $762K | Buy |
15,546
+360
| +2% | +$16.8K | 0.02% | 424 |
|
|
2025
Q3 | $655K | Sell |
15,186
-3,726
| -20% | -$146K | 0.02% | 432 |
|
|
2025
Q2 | $726K | Buy |
18,912
+652
| +4% | +$24.9K | 0.03% | 374 |
|
|
2025
Q1 | $707K | Buy |
18,260
+6,372
| +54% | +$233K | 0.03% | 379 |
|
|
2024
Q4 | $402K | Sell |
11,888
-1,129
| -9% | -$40.6K | 0.01% | 623 |
|
|
2024
Q3 | $532K | Sell |
13,017
-1,962
| -13% | -$80.3K | 0.02% | 508 |
|
|
2024
Q2 | $577K | Buy |
14,979
+433
| +3% | +$18.2K | 0.02% | 456 |
|
|
2024
Q1 | $624K | Sell |
14,546
-2,038
| -12% | -$84K | 0.02% | 501 |
|
|
2023
Q4 | $615K | Buy |
16,584
+7,149
| +76% | +$257K | 0.03% | 453 |
|
|
2023
Q3 | $342K | Sell |
9,435
-558
| -6% | -$19.8K | 0.02% | 599 |
|
|
2023
Q2 | $356K | Sell |
9,993
-1,912
| -16% | -$68.6K | 0.02% | 631 |
|
|
2023
Q1 | $424K | Buy |
11,905
+908
| +8% | +$31.8K | 0.03% | 555 |
|
|
2022
Q4 | $386K | Sell |
10,997
-2,226
| -17% | -$74.1K | 0.03% | 517 |
|
|
2022
Q3 | $389K | Sell |
13,223
-1,524
| -10% | -$57.8K | 0.03% | 467 |
|
|
2022
Q2 | $802K | Sell |
14,747
-1,632
| -10% | -$90.1K | 0.05% | 306 |
|
|
2022
Q1 | $892K | Buy |
16,379
+1,508
| +10% | +$81.9K | 0.04% | 350 |
|
|
2021
Q4 | $820K | Buy |
14,871
+925
| +7% | +$48.1K | 0.03% | 391 |
|
|
2021
Q3 | $666K | Buy |
13,946
+581
| +4% | +$29.2K | 0.02% | 497 |
|
|
2021
Q2 | $666K | Buy |
13,365
+357
| +3% | +$17.2K | 0.02% | 518 |
|
|
2021
Q1 | $580K | Buy |
13,008
+458
| +4% | +$20.8K | 0.02% | 510 |
|
|
2020
Q4 | $577K | Sell |
12,550
-125
| -1% | -$5.74K | 0.03% | 483 |
|
|
2020
Q3 | $596K | Sell |
12,675
-2,359
| -16% | -$118K | 0.03% | 406 |
|
|
2020
Q2 | $767K | Buy |
15,034
+2,732
| +22% | +$140K | 0.04% | 313 |
|
|
2020
Q1 | $583K | Sell |
12,302
-4,640
| -27% | -$248K | 0.04% | 322 |
|
|
2019
Q4 | $995K | Sell |
16,942
-123
| -0.7% | -$6.84K | 0.04% | 351 |
|
|
2019
Q3 | $910K | Sell |
17,065
-2,278
| -12% | -$117K | 0.05% | 348 |
|
|
2019
Q2 | $968K | Buy |
19,343
+273
| +1% | +$13.7K | 0.05% | 377 |
|
|
2019
Q1 | $996K | Buy |
19,070
+3,125
| +20% | +$156K | 0.05% | 338 |
|
|
2018
Q4 | $762K | Sell |
15,945
-5,562
| -26% | -$274K | 0.05% | 344 |
|
|
2018
Q3 | $1.08M | Sell |
21,507
-376
| -2% | -$19.1K | 0.04% | 372 |
|
|
2018
Q2 | $1.1M | Sell |
21,883
-1,203
| -5% | -$60.6K | 0.04% | 350 |
|
|
2018
Q1 | $1.13M | Sell |
23,086
-18,725
| -45% | -$872K | 0.04% | 363 |
|
|
2017
Q4 | $1.85M | Buy |
41,811
+1,215
| +3% | +$56.1K | 0.07% | 256 |
|
|
2017
Q3 | $2.06M | Buy |
40,596
+10,948
| +37% | +$555K | 0.09% | 215 |
|
|
2017
Q2 | $1.6M | Sell |
29,648
-8,024
| -21% | -$428K | 0.07% | 244 |
|
|
2017
Q1 | $1.99M | Buy |
37,672
+12,716
| +51% | +$645K | 0.09% | 196 |
|
|
2016
Q4 | $1.2M | Buy |
24,956
+2,612
| +12% | +$129K | 0.06% | 336 |
|
|
2016
Q3 | $1.21M | Buy |
22,344
+1,848
| +9% | +$101K | 0.06% | 316 |
|
|
2016
Q2 | $1.11M | Sell |
20,496
-5,152
| -20% | -$271K | 0.05% | 341 |
|
|
2016
Q1 | $1.3M | Buy |
25,648
+1,400
| +6% | +$69.7K | 0.07% | 257 |
|
|
2015
Q4 | $1.22M | Buy |
24,248
+3,472
| +17% | +$177K | 0.06% | 290 |
|
|
2015
Q3 | $999K | Sell |
20,776
-10,584
| -34% | -$551K | 0.06% | 286 |
|
|
2015
Q2 | $1.63M | Buy |
31,360
+728
| +2% | +$41K | 0.07% | 238 |
|
|
2015
Q1 | $1.77M | Buy |
30,632
+5,880
| +24% | +$337K | 0.07% | 246 |
|
|
2014
Q4 | $1.32M | Buy |
24,752
+5,658
| +30% | +$317K | 0.05% | 324 |
|
|
2014
Q3 | $1.1M | Sell |
19,094
-10,858
| -36% | -$666K | 0.05% | 350 |
|
|
2014
Q2 | $2M | Buy |
29,952
+5,242
| +21% | +$355K | 0.09% | 215 |
|
|
2014
Q1 | $1.65M | Sell |
24,710
-1,332
| -5% | -$90K | 0.08% | 238 |
|
|
2013
Q4 | $1.74M | Buy |
26,042
+3,398
| +15% | +$220K | 0.08% | 218 |
|
|
2013
Q3 | $1.42M | Buy |
22,644
+10,152
| +81% | +$653K | 0.08% | 268 |
|
|
2013
Q2 | $780K | Buy |
+12,492
| New | +$793K | 0.06% | 370 |
|
Other funds holding GSK
JEST
Profund Advisors's GSK Position: Q2 2026 in Review
Profund Advisors reduced its GSK (GSK) stake by 2.8% in Q2 2026, selling an estimated $19.9K and leaving 13,076 shares worth $685K. The position accounts for 0.02% of the portfolio, ranked #448.
Profund Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.06M in Q3 2017. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Profund Advisors held 13,076 shares of GSK worth $685K as of Q2 2026.
- Profund Advisors sold 377 GSK shares in Q2 2026, an estimated $19.9K.
- GSK made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #448 holding.
- Profund Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Profund Advisors's GSK position peaked at $2.06M in Q3 2017.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.